ResoTher Pharma

Keiretsu Forum NordicsPortfolio

ResoTher Pharma is developing a new cardioprotective drug for patients who have just suffered a heart attack.
ResoTher Pharma is a privately held biotechnology company located in Copenhagen, Denmark. The company is focused on developing peptide-based drugs derived from the endogenous immunomodulator Annexin A1 as resolution therapy for diseases where neutrophil-driven inflammation plays a key pathological role. Our current focus is on cardiovascular disorders and inflammatory disorders with a large unmet medical need.